Rubio, Rosen Reintroduce Bipartisan Legislation to Study the Full Health Impacts of Covid-19
Feb 03 2021
Washington, D.C. — U.S. Senators Marco Rubio (R-FL) and Jacky Rosen (D-NV) reintroduced the bipartisan Ensuring Understanding of COVID-19 to Protect Public Health Act, legislation that would direct the National Institutes of Health (NIH) to conduct a longitudinal study on mild, moderate, and severe cases of COVID-19 to ensure we gain a full understanding of both the short and long-term health impacts of the novel coronavirus. Rubio and Rosen first introduced the legislation in May 2020.
“As our nation continues to battle the coronavirus pandemic, it is critical that our health care experts at the NIH conduct a comprehensive study to help guide physicians caring for patients with COVID-19,” Rubio said. “There are still numerous unknowns about COVID-19, including its potential long-term health impacts, and this bipartisan bill provides the NIH with important guidelines to study this virus.”
“As our country continues to battle this virus, we must ensure we continue to examine all aspects of how COVID-19 affects patients from diverse populations,” Rosen said. “By focusing our nation’s efforts toward understanding the short and long-term health ramifications of COVID-19, we can arm our researchers and medical professionals with the most accurate data as they work to provide better treatment and vaccines for patients. I will continue working to protect the health of Nevadans during this unprecedented time.”
Background: More specifically, the bipartisan Ensuring Understanding of COVID-19 to Protect Public Health Act would direct the NIH to:
Conduct a nationwide study of the health outcomes and symptoms of COVID-19, including long-term impact on lung function and immune response, and the impact of treatments.
The study would include a wide variety of patients, to ensure diversity among race, ethnicity, geography, age, gender, and underlying health conditions; and
Monitor mental health outcomes.
The goal of the study is to gain a full understanding of both the short-term and long-term health impacts of COVID-19.
The findings would be released publicly every 3 months for the first two years, and every 6 months thereafter.